Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Bacterial Infections and Mycoses

  Free Subscription


Articles published in PLoS Med

Retrieve available abstracts of 29 articles:
HTML format



Single Articles


    February 2026
  1. PORTNOY A, Clark RA, Jit M, McQuaid CF, et al
    The potential impact of reduced international donor funding on the household economic burden of tuberculosis in low- and middle-income countries: A modeling study.
    PLoS Med. 2026;23:e1004946.
    PubMed     Abstract available


  2. TANVIR H, Clark RA, Sumner T, Horton KC, et al
    Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling study.
    PLoS Med. 2026;23:e1004595.
    PubMed     Abstract available


  3. SCHWALB A, Dodd PJ, Rickman HM, Ugarte-Gil CA, et al
    Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling study.
    PLoS Med. 2026;23:e1004920.
    PubMed     Abstract available


  4. DUROVNI B, Cordeiro-Santos M, Cavalcante SC, Spener-Gomes R, et al
    Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial.
    PLoS Med. 2026;23:e1004758.
    PubMed     Abstract available


    January 2026
  5. STANTON TD, Keegan SP, Abdulahi JA, Amulele AV, et al
    Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: A meta-analysis of genome-predicted serotype prevalence to inform potential vaccine coverage.
    PLoS Med. 2026;23:e1004879.
    PubMed     Abstract available


    December 2025
  6. GOTTLIEB SL, Rees H, Peters RPH
    Vaccines to prevent bacterial sexually transmitted infections: Promise, progress, and public health potential.
    PLoS Med. 2025;22:e1004849.
    PubMed     Abstract available


    November 2025
  7. HEITKAMP P, Chijioke-Akaniro O, Pai M
    From dependence to self-reliance: The future of the global tuberculosis response.
    PLoS Med. 2025;22:e1004824.
    PubMed     Abstract available


  8. WATERLOW NR, Chandler CIR, Cooper BS, Moore CE, et al
    Combining demographic shifts with age-based resistance prevalence to estimate future antimicrobial resistance burden in Europe and implications for targets: A modelling study.
    PLoS Med. 2025;22:e1004579.
    PubMed     Abstract available


  9. OLBRICH L, Larsson L, Dunbar R, Dodd PJ, et al
    Diagnostic accuracy of the WHO tuberculosis treatment decision algorithms for children with presumptive tuberculosis: An individual participant data meta-analysis.
    PLoS Med. 2025;22:e1004610.
    PubMed     Abstract available


    July 2025
  10. ADJOBIMEY M, Trajman A, Bastos ML, Valiquette C, et al
    Rapid molecular testing or chest X-ray or tuberculin skin testing for household contact assessment of tuberculosis infection: A cluster-randomized trial.
    PLoS Med. 2025;22:e1004666.
    PubMed     Abstract available


    June 2025
  11. OSENA G, Kapoor G, Kalanxhi E, Ouassa T, et al
    Antimicrobial resistance in Africa: A retrospective analysis of data from 14 countries, 2016-2019.
    PLoS Med. 2025;22:e1004638.
    PubMed     Abstract available


    May 2025
  12. HSIEH YL, Horsburgh CR Jr, Cohen T, Miller JW, et al
    Cost-effectiveness of screening with transcriptional signatures for incipient TB among U.S. migrants.
    PLoS Med. 2025;22:e1004603.
    PubMed     Abstract available


    February 2025
  13. GENG L, Whittles LK, Dickens BL, Chio MTW, et al
    Potential public health impacts of gonorrhea vaccination programmes under declining incidences: A modeling study.
    PLoS Med. 2025;22:e1004521.
    PubMed     Abstract available


    January 2025
  14. KIM S, Can MH, Agizew TB, Auld AF, et al
    Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis.
    PLoS Med. 2025;22:e1004502.
    PubMed     Abstract available


    December 2024
  15. KEOGH-BROWN MR, Sumner T, Sweeney S, Vassall A, et al
    Estimating the health and macroeconomic burdens of tuberculosis in India, 2021-2040: A fully integrated modelling study.
    PLoS Med. 2024;21:e1004491.
    PubMed     Abstract available


    November 2024
  16. MACPHERSON P, Stagg HR, Schwalb A, Henderson H, et al
    Impact of active case finding for tuberculosis with mass chest X-ray screening in Glasgow, Scotland, 1950-1963: An epidemiological analysis of historical data.
    PLoS Med. 2024;21:e1004448.
    PubMed     Abstract available


    October 2024
  17. DE JONG BC, Nourdine S, Bergeman AT, Salim Z, et al
    Safety of single-dose bedaquiline combined with rifampicin for leprosy post-exposure prophylaxis: A Phase 2 randomized non-inferiority trial in the Comoros Islands.
    PLoS Med. 2024;21:e1004453.
    PubMed     Abstract available


    September 2024
  18. CALDERWOOD CJ, Marambire ET, Larsson L, Banze D, et al
    HIV, malnutrition, and noncommunicable disease epidemics among tuberculosis-affected households in east and southern Africa: A cross-sectional analysis of the ERASE-TB cohort.
    PLoS Med. 2024;21:e1004452.
    PubMed     Abstract available


    July 2024
  19. BURMAN W, Rucsineanu O, Horsburgh CR, Johnston J, et al
    Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach.
    PLoS Med. 2024;21:e1004438.
    PubMed     Abstract available


  20. YIN X, Li Y, Ronn MM, Li S, et al
    Assessing thresholds of resistance prevalence at which empiric treatment of gonorrhea should change among men who have sex with men in the US: A cost-effectiveness analysis.
    PLoS Med. 2024;21:e1004424.
    PubMed     Abstract available


  21. LECLERC QJ, Duval A, Guillemot D, Opatowski L, et al
    Using contact network dynamics to implement efficient interventions against pathogen spread in hospital settings: A modelling study.
    PLoS Med. 2024;21:e1004433.
    PubMed     Abstract available


    June 2024
  22. PEREZ CHACON G, Estcourt MJ, Totterdell J, Marsh JA, et al
    Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial.
    PLoS Med. 2024;21:e1004414.
    PubMed     Abstract available


  23. LEACH AJ, Wilson N, Arrowsmith B, Beissbarth J, et al
    Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules.
    PLoS Med. 2024;21:e1004375.
    PubMed     Abstract available


    May 2024
  24. JHAVERI TA, Jhaveri D, Galivanche A, Lubeck-Schricker M, et al
    Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies.
    PLoS Med. 2024;21:e1004409.
    PubMed     Abstract available


  25. JAMES LP, Klaassen F, Sweeney S, Furin J, et al
    Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.
    PLoS Med. 2024;21:e1004401.
    PubMed     Abstract available


  26. MICHALOW J, Walters MK, Edun O, Wybrant M, et al
    Aetiology of vaginal discharge, urethral discharge, and genital ulcer in sub-Saharan Africa: A systematic review and meta-regression.
    PLoS Med. 2024;21:e1004385.
    PubMed     Abstract available


  27. OKEEFFE J, Salem-Bango L, Desjardins MR, Lantagne D, et al
    Case-area targeted interventions during a large-scale cholera epidemic: A prospective cohort study in Northeast Nigeria.
    PLoS Med. 2024;21:e1004404.
    PubMed     Abstract available


    April 2024
  28. CHEN L, Xing Y, Zhang Y, Xie J, et al
    Long-term variations of urban-Rural disparities in infectious disease burden of over 8.44 million children, adolescents, and youth in China from 2013 to 2021: An observational study.
    PLoS Med. 2024;21:e1004374.
    PubMed     Abstract available


    March 2024
  29. EMANI S, Alves K, Alves LC, da Silva DA, et al
    Quantifying gaps in the tuberculosis care cascade in Brazil: A mathematical model study using national program data.
    PLoS Med. 2024;21:e1004361.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum